News
Industrial Boiler Water Treatment: Best Practices For Modern Plant Operations
Industrial boilers sit at the center of many plant operations, from heating and power to a wide range of industrial process needs. Because they run for long...
BioPharma
Regeneron Looks to Infusing More Funds into Gene Editing
Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025, so as to...
News
How Poor Medical Care in Nursing Homes Leads to Preventable Health Complications
Older adults in nursing homes rely on consistent, accurate medical care to stay healthy. Simple health issues can turn into serious complications when that care falls below...
News
Addressing Industrial Health Risks: Pharma’s Key Role
Workers in various industries face significant health risks due to exposure to hazardous chemicals, toxic materials, and unsafe working conditions. These risks can lead to severe long-term...
BioPharma
Transforming Clinical Trials Automation and Sustainability
In a time of fast technological change and rising environmental awareness, the pharmaceutical industry is looking for new ways to stay ahead. Because of this work, automation...
Press Releases
Symbiosis Formally Presented with Prestigious King’s Award by Lord Lieutenant of Stirling and Falkirk
Symbiosis Pharmaceutical Services (Symbiosis), a global biopharmaceutical Contract Manufacturing Organisation (CMO) specialising in the sterile fill finish of injectable drug products, has been formally presented with a 2025...
News
Iraq To Open Largest Cancer Drug Factory in The Region
Iraq looks forward to inaugurating the region’s largest cancer drug factory in Abu Ghraib, which is situated 32 kilometers – equivalent to 20 miles west of Baghdad,...
News
The Future of Health and Wellbeing: A Market on the Rise
The health and wellbeing market has experienced significant growth over the past decade, driven by an increasing awareness of physical and mental health issues. As we look...
News
Synthetic Drugs: A Growing Crisis or Signs of Improvement?
The landscape of drug usage has undergone significant changes in recent years, particularly with the rise of synthetic drugs. These substances, often engineered to mimic the effects...
BioPharma
Eli Lilly Becomes the First Drugmaker to Hit $1tn Valuation
Eli Lilly, the US pharma giant, has become the first drugmaker to hit $1tn valuation on November 22, 2025, hence entering the exclusive club, which is so...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
















